Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis

International Neurourology Journal - South Korea
doi 10.5213/inj.2011.15.2.61
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Continence Society

Related search

Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation

International Neurourology Journal
NeurologyUrology
2015English

A Central Role for Toll-Like 4 (TLR4) Receptors in Interstitial Cystitis?

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2018English

Interstitial Cystitis and Infectious Agents

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2005English

An Overview of Mast Cell Pattern Recognition Receptors

Inflammation Research
ImmunologyPharmacology
2018English

Verification of Mesenchymal Stem Cell Injection Therapy for Interstitial Cystitis in a Rat Model

PLoS ONE
Multidisciplinary
2019English

Purinergic P2X7 Receptors as Therapeutic Targets in Interstitial Cystitis/Bladder Pain Syndrome; Key Role of ATP Signaling in Inflammation

Bladder
2019English

Pharmacologic Management of Painful Bladder Syndrome/Interstitial Cystitis

Archives of Internal Medicine
2007English

Personal Cell Therapy for Interstitial Cystitis With Autologous Stromal Vascular Fraction Stem Cells

Therapeutic Advances in Urology
Urology
2019English

Comparison of an Interstitial Cystitis/Bladder Pain Syndrome Clinical Cohort With Symptomatic Community Women From the RAND Interstitial Cystitis Epidemiology Study

Journal of Urology
Urology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy